SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '9CP'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GHM_A_CEDA1_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	7 / 12	ALA A 80 SER A 81 SER A 128 LYS A 218 SER A 219 GLY A 220 ARG A 261	9CP A 306 (-3.3A) 9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-3.0A) 9CP A 306 (-2.9A) 9CP A 306 (-3.5A) 9CP A 306 (-2.7A)	0.63A	1ghmA-5vfdA: 17.8	1ghmA-5vfdA: 24.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NY4_A_SMXA308_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	6 / 12	SER A 81 SER A 128 ARG A 261 LYS A 218 GLY A 220 GLY A 222	9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-2.7A) 9CP A 306 (-3.0A) 9CP A 306 (-3.5A) 9CP A 306 ( 4.4A)	0.94A	3ny4A-5vfdA: 18.9	3ny4A-5vfdA: 22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_A_CEDA1_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	6 / 12	ALA A 80 SER A 81 SER A 128 LYS A 218 GLY A 220 ARG A 261	9CP A 306 (-3.3A) 9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-3.0A) 9CP A 306 (-3.5A) 9CP A 306 (-2.7A)	0.59A	3sh8A-5vfdA: 19.2	3sh8A-5vfdA: 23.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_B_CEDB1_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	6 / 12	ALA A 80 SER A 81 SER A 128 LYS A 218 GLY A 220 ARG A 261	9CP A 306 (-3.3A) 9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-3.0A) 9CP A 306 (-3.5A) 9CP A 306 (-2.7A)	0.58A	3sh8B-5vfdA: 19.3	3sh8B-5vfdA: 23.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_A_CEDA301_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	6 / 12	ALA A 80 SER A 81 SER A 128 LYS A 218 GLY A 220 ARG A 261	9CP A 306 (-3.3A) 9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-3.0A) 9CP A 306 (-3.5A) 9CP A 306 (-2.7A)	0.61A	4n9kA-5vfdA: 19.1	4n9kA-5vfdA: 23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_B_CEDB301_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	6 / 12	ALA A 80 SER A 81 SER A 128 LYS A 218 GLY A 220 ARG A 261	9CP A 306 (-3.3A) 9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-3.0A) 9CP A 306 (-3.5A) 9CP A 306 (-2.7A)	0.58A	4n9kB-5vfdA: 19.2	4n9kB-5vfdA: 23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Q15_A_HFGA803_0 (PROLINE--TRNA LIGASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	5 / 12	LEU A 168 VAL A 130 THR A 82 SER A 247 GLY A 234	9CP A 306 ( 4.6A) KCX A 84 (-3.8A) None None None	1.06A	4q15A-5vfdA: undetectable	4q15A-5vfdA: 20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_A_CEDA301_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	6 / 12	ALA A 80 SER A 81 SER A 128 LYS A 218 GLY A 220 ARG A 261	9CP A 306 (-3.3A) 9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-3.0A) 9CP A 306 (-3.5A) 9CP A 306 (-2.7A)	0.59A	5ghyA-5vfdA: 19.3	5ghyA-5vfdA: 23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_B_CEDB301_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	6 / 12	ALA A 80 SER A 81 SER A 128 LYS A 218 GLY A 220 ARG A 261	9CP A 306 (-3.3A) 9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-3.0A) 9CP A 306 (-3.5A) 9CP A 306 (-2.7A)	0.58A	5ghyB-5vfdA: 19.3	5ghyB-5vfdA: 23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_A_CEDA301_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	6 / 11	ALA A 80 SER A 81 SER A 128 LYS A 218 GLY A 220 ARG A 261	9CP A 306 (-3.3A) 9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-3.0A) 9CP A 306 (-3.5A) 9CP A 306 (-2.7A)	0.58A	5ghzA-5vfdA: 19.1	5ghzA-5vfdA: 23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_B_CEDB301_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	6 / 10	ALA A 80 SER A 81 SER A 128 LYS A 218 GLY A 220 ARG A 261	9CP A 306 (-3.3A) 9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-3.0A) 9CP A 306 (-3.5A) 9CP A 306 (-2.7A)	0.60A	5ghzB-5vfdA: 19.1	5ghzB-5vfdA: 23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	6 / 12	SER A 81 SER A 128 ARG A 261 LYS A 218 GLY A 220 GLY A 222	9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-2.7A) 9CP A 306 (-3.0A) 9CP A 306 (-3.5A) 9CP A 306 ( 4.4A)	0.92A	6b5yB-5vfdA: 19.0	6b5yB-5vfdA: 17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	6 / 12	SER A 81 SER A 128 ARG A 261 LYS A 218 GLY A 220 GLY A 222	9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-2.7A) 9CP A 306 (-3.0A) 9CP A 306 (-3.5A) 9CP A 306 ( 4.4A)	0.89A	6b68D-5vfdA: 18.9	6b68D-5vfdA: 17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	6 / 12	SER A 81 SER A 128 ARG A 261 LYS A 218 GLY A 220 GLY A 222	9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-2.7A) 9CP A 306 (-3.0A) 9CP A 306 (-3.5A) 9CP A 306 ( 4.4A)	0.85A	6b69D-5vfdA: 18.9	6b69D-5vfdA: 17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	6 / 12	SER A 81 SER A 128 ARG A 261 LYS A 218 GLY A 220 GLY A 222	9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-2.7A) 9CP A 306 (-3.0A) 9CP A 306 (-3.5A) 9CP A 306 ( 4.4A)	0.86A	6b6aB-5vfdA: 19.0	6b6aB-5vfdA: 17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	6 / 12	SER A 81 SER A 128 ARG A 261 LYS A 218 GLY A 220 GLY A 222	9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-2.7A) 9CP A 306 (-3.0A) 9CP A 306 (-3.5A) 9CP A 306 ( 4.4A)	0.84A	6b6aD-5vfdA: 18.9	6b6aD-5vfdA: 17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	6 / 12	SER A 81 SER A 128 ARG A 261 LYS A 218 GLY A 220 GLY A 222	9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-2.7A) 9CP A 306 (-3.0A) 9CP A 306 (-3.5A) 9CP A 306 ( 4.4A)	0.90A	6b6cA-5vfdA: 19.0	6b6cA-5vfdA: 17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	5vfd	BETA-LACTAMASE (Acinetobacter baumannii)	6 / 12	SER A 81 SER A 128 ARG A 261 LYS A 218 GLY A 220 GLY A 222	9CP A 306 (-1.4A) 9CP A 306 (-2.8A) 9CP A 306 (-2.7A) 9CP A 306 (-3.0A) 9CP A 306 (-3.5A) 9CP A 306 ( 4.4A)	0.86A	6b6eA-5vfdA: 19.0	6b6eA-5vfdA: 17.22

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1GHM_A_CEDA1_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",7,"ALA A  80;SER A  81;SER A 128;LYS A 218;SER A 219;GLY A 220;ARG A 261","9CP A 306 (-3.3A);9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-3.0A);9CP A 306 (-2.9A);9CP A 306 (-3.5A);9CP A 306 (-2.7A)","0.63A","1ghmA-5vfdA:17.8",null],["3NY4_A_SMXA308_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",6,"SER A  81;SER A 128;ARG A 261;LYS A 218;GLY A 220;GLY A 222","9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-2.7A);9CP A 306 (-3.0A);9CP A 306 (-3.5A);9CP A 306 ( 4.4A)","0.94A","3ny4A-5vfdA:18.9","1ghmA-5vfdA:24.91"],["3SH8_A_CEDA1_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",6,"ALA A  80;SER A  81;SER A 128;LYS A 218;GLY A 220;ARG A 261","9CP A 306 (-3.3A);9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-3.0A);9CP A 306 (-3.5A);9CP A 306 (-2.7A)","0.59A","3sh8A-5vfdA:19.2","3ny4A-5vfdA:22.76"],["3SH8_B_CEDB1_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",6,"ALA A  80;SER A  81;SER A 128;LYS A 218;GLY A 220;ARG A 261","9CP A 306 (-3.3A);9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-3.0A);9CP A 306 (-3.5A);9CP A 306 (-2.7A)","0.58A","3sh8B-5vfdA:19.3","3sh8A-5vfdA:23.57"],["4N9K_A_CEDA301_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",6,"ALA A  80;SER A  81;SER A 128;LYS A 218;GLY A 220;ARG A 261","9CP A 306 (-3.3A);9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-3.0A);9CP A 306 (-3.5A);9CP A 306 (-2.7A)","0.61A","4n9kA-5vfdA:19.1","3sh8B-5vfdA:23.57"],["4N9K_B_CEDB301_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",6,"ALA A  80;SER A  81;SER A 128;LYS A 218;GLY A 220;ARG A 261","9CP A 306 (-3.3A);9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-3.0A);9CP A 306 (-3.5A);9CP A 306 (-2.7A)","0.58A","4n9kB-5vfdA:19.2","4n9kA-5vfdA:23.21"],["4Q15_A_HFGA803_0","PROLINE--TRNA LIGASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",5,"LEU A 168;VAL A 130;THR A  82;SER A 247;GLY A 234","9CP A 306 ( 4.6A);KCX A  84 (-3.8A);None;None;None","1.06A","4q15A-5vfdA:undetectable","4n9kB-5vfdA:23.21"],["5GHY_A_CEDA301_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",6,"ALA A  80;SER A  81;SER A 128;LYS A 218;GLY A 220;ARG A 261","9CP A 306 (-3.3A);9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-3.0A);9CP A 306 (-3.5A);9CP A 306 (-2.7A)","0.59A","5ghyA-5vfdA:19.3","4q15A-5vfdA:20.79"],["5GHY_B_CEDB301_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",6,"ALA A  80;SER A  81;SER A 128;LYS A 218;GLY A 220;ARG A 261","9CP A 306 (-3.3A);9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-3.0A);9CP A 306 (-3.5A);9CP A 306 (-2.7A)","0.58A","5ghyB-5vfdA:19.3","5ghyA-5vfdA:23.21"],["5GHZ_A_CEDA301_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",6,"ALA A  80;SER A  81;SER A 128;LYS A 218;GLY A 220;ARG A 261","9CP A 306 (-3.3A);9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-3.0A);9CP A 306 (-3.5A);9CP A 306 (-2.7A)","0.58A","5ghzA-5vfdA:19.1","5ghyB-5vfdA:23.21"],["5GHZ_B_CEDB301_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",6,"ALA A  80;SER A  81;SER A 128;LYS A 218;GLY A 220;ARG A 261","9CP A 306 (-3.3A);9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-3.0A);9CP A 306 (-3.5A);9CP A 306 (-2.7A)","0.60A","5ghzB-5vfdA:19.1","5ghzA-5vfdA:23.21"],["6B5Y_B_9F2B400_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",6,"SER A  81;SER A 128;ARG A 261;LYS A 218;GLY A 220;GLY A 222","9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-2.7A);9CP A 306 (-3.0A);9CP A 306 (-3.5A);9CP A 306 ( 4.4A)","0.92A","6b5yB-5vfdA:19.0","5ghzB-5vfdA:23.21"],["6B68_D_9F2D400_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",6,"SER A  81;SER A 128;ARG A 261;LYS A 218;GLY A 220;GLY A 222","9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-2.7A);9CP A 306 (-3.0A);9CP A 306 (-3.5A);9CP A 306 ( 4.4A)","0.89A","6b68D-5vfdA:18.9","6b5yB-5vfdA:17.22"],["6B69_D_9F2D301_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",6,"SER A  81;SER A 128;ARG A 261;LYS A 218;GLY A 220;GLY A 222","9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-2.7A);9CP A 306 (-3.0A);9CP A 306 (-3.5A);9CP A 306 ( 4.4A)","0.85A","6b69D-5vfdA:18.9","6b68D-5vfdA:17.22"],["6B6A_B_9F2B301_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",6,"SER A  81;SER A 128;ARG A 261;LYS A 218;GLY A 220;GLY A 222","9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-2.7A);9CP A 306 (-3.0A);9CP A 306 (-3.5A);9CP A 306 ( 4.4A)","0.86A","6b6aB-5vfdA:19.0","6b69D-5vfdA:17.22"],["6B6A_D_9F2D301_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",6,"SER A  81;SER A 128;ARG A 261;LYS A 218;GLY A 220;GLY A 222","9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-2.7A);9CP A 306 (-3.0A);9CP A 306 (-3.5A);9CP A 306 ( 4.4A)","0.84A","6b6aD-5vfdA:18.9","6b6aB-5vfdA:17.22"],["6B6C_A_9F2A301_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",6,"SER A  81;SER A 128;ARG A 261;LYS A 218;GLY A 220;GLY A 222","9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-2.7A);9CP A 306 (-3.0A);9CP A 306 (-3.5A);9CP A 306 ( 4.4A)","0.90A","6b6cA-5vfdA:19.0","6b6aD-5vfdA:17.22"],["6B6E_A_9F2A302_1","BETA-LACTAMASE","5vfd","BETA-LACTAMASE","Acinetobacter baumannii",6,"SER A  81;SER A 128;ARG A 261;LYS A 218;GLY A 220;GLY A 222","9CP A 306 (-1.4A);9CP A 306 (-2.8A);9CP A 306 (-2.7A);9CP A 306 (-3.0A);9CP A 306 (-3.5A);9CP A 306 ( 4.4A)","0.86A","6b6eA-5vfdA:19.0","6b6cA-5vfdA:17.22"]]